A NantHealth investor filed suit in federal court this week against Dr. Patrick Soon-Shiong and his health technology company, alleging violations of federal securities laws. The lawsuit follows the publication of a STAT investigation that showed how the biotech billionaire used a philanthropic donation to steer business back to his company.

The suit was filed on behalf of a single investor; the complaint indicated that the legal team may ask a judge to expand it to a class action if additional investors come forward.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Let’s see, Rebecca is reporting that a single investor has filed lawsuit against NH based on her STAT article? Would any real newspaper report this? Never. Shareholder lawsuits are filed all the time and never amount to anything. Why would any newspaper report on a single investor filing a shareholder lawsuit against a company? Would she write an article if I filed a meaningless lawsuit against her? These are the tactics of a pure smear campaign, not journalism.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy